Is Aristo Bio-Tech overvalued or undervalued?
As of August 26, 2025, Aristo Bio-Tech is fairly valued with a PE ratio of 20.22 and a PEG ratio of 4.93, indicating high growth expectations, while its recent stock performance has outpaced the Sensex.
As of 26 August 2025, the valuation grade for Aristo Bio-Tech has moved from expensive to fair. The company is currently fairly valued, with a PE ratio of 20.22, an EV to EBITDA of 11.09, and a Price to Book Value of 2.20. In comparison to peers, Sharda Cropchem, which is also rated fair, has a slightly higher PE ratio of 20.78, while UPL, rated attractive, has a significantly higher PE of 36.17.Despite the fair valuation, Aristo Bio-Tech's PEG ratio of 4.93 suggests that growth expectations may be high relative to its earnings. The company's recent stock performance has outpaced the Sensex over the past week, with a return of 4.42% compared to a decline of 1.08% for the index. Overall, while the company is fairly valued, potential investors should consider its growth prospects in relation to its valuation metrics.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
